Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in …

NL Albert, M Weller, B Suchorska, N Galldiks… - Neuro …, 2016 - academic.oup.com
This guideline provides recommendations for the use of PET imaging in gliomas. The review
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …

Glioblastoma

HG Wirsching, M Weller - Malignant Brain Tumors: State-of-the-Art …, 2017 - Springer
Glioblastoma is the most aggressive and the most common primary malignant brain tumor in
adults. Risk factors for glioblastoma are widely elusive and the clinical course is generally …

[HTML][HTML] Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG …

I Law, NL Albert, J Arbizu, R Boellaard… - European journal of …, 2019 - Springer
These joint practice guidelines, or procedure standards, were developed collaboratively by
the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and …

Advances in neuro-oncology imaging

KJ Langen, N Galldiks, E Hattingen… - Nature Reviews …, 2017 - nature.com
Despite the fact that MRI has evolved to become the standard method for diagnosis and
monitoring of patients with brain tumours, conventional MRI sequences have two key …

Radiation necrosis, pseudoprogression, pseudoresponse, and tumor recurrence: imaging challenges for the evaluation of treated gliomas

A Zikou, C Sioka, GA Alexiou… - Contrast media & …, 2018 - Wiley Online Library
Glioblastoma (GBM) is the most common primary malignant type of brain neoplasm in adults
and carries a dismal prognosis. The current standard of care for GBM is surgical excision …

Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients-a report of the PET/RANO group

N Galldiks, M Niyazi, AL Grosu, M Kocher… - Neuro …, 2021 - academic.oup.com
The management of patients with glioma usually requires multimodality treatment including
surgery, radiotherapy, and systemic therapy. Accurate neuroimaging plays a central role for …

[HTML][HTML] How to differentiate pseudoprogression from true progression in cancer patients treated with immunotherapy

Y Ma, Q Wang, Q Dong, L Zhan… - American journal of …, 2019 - ncbi.nlm.nih.gov
Immunotherapy has achieved unprecedented clinical efficacy in patients with various types
of advanced tumors; however, some patients experience delayed tumor shrinkage following …

PET imaging in patients with brain metastasis—report of the RANO/PET group

N Galldiks, KJ Langen, NL Albert… - Neuro …, 2019 - academic.oup.com
Brain metastases (BM) from extracranial cancer are associated with significant morbidity and
mortality. Effective local treatment options are stereotactic radiotherapy, including …

Pseudoprogression, radionecrosis, inflammation or true tumor progression? Challenges associated with glioblastoma response assessment in an evolving …

BM Ellingson, C Chung, WB Pope, JL Boxerman… - Journal of neuro …, 2017 - Springer
The wide variety of treatment options that exist for glioblastoma, including surgery, ionizing
radiation, anti-neoplastic chemotherapies, anti-angiogenic therapies, and active or passive …

Radiomics in neuro-oncology: Basics, workflow, and applications

P Lohmann, N Galldiks, M Kocher, A Heinzel, CP Filss… - Methods, 2021 - Elsevier
Over the last years, the amount, variety, and complexity of neuroimaging data acquired in
patients with brain tumors for routine clinical purposes and the resulting number of imaging …